Advertisement

Index by author

May 01, 1983; Volume 23,Issue 3

A

  1. Allen, D L

    1. A portion of [3H]cocaine binding in brain is associated with serotonergic neurons.
      M E Reith, H Sershen, D L Allen and A Lajtha
      Molecular Pharmacology May 1983, 23 (3) 600-606;

B

  1. Ballot, B A

    1. Inhibition of human platelet aggregation by S-nitrosothiols. Heme-dependent activation of soluble guanylate cyclase and stimulation of cyclic GMP accumulation.
      B T Mellion, L J Ignarro, C B Myers, E H Ohlstein, B A Ballot, A L Hyman and P J Kadowitz
      Molecular Pharmacology May 1983, 23 (3) 653-664;

  2. Barnes, P J

    1. Postsynaptic alpha 2-adrenoceptors predominate over alpha 1-adrenoceptors in canine tracheal smooth muscle and mediate neuronal and hormonal alpha-adrenergic contraction.
      P J Barnes, B E Skoogh, J A Nadel and J M Roberts
      Molecular Pharmacology May 1983, 23 (3) 570-575;

  3. Benga, G

    1. Effect of chlorpromazine on proteins in human erythrocyte membranes as inferred from spin labeling and biochemical analyses.
      G Benga, M Ionescu, O Popescu and V I Pop
      Molecular Pharmacology May 1983, 23 (3) 771-778;

  4. Bessler, W G

    1. Interaction of metal-complexing compounds with lymphocytes and lymphoid cell lines.
      G Jung, G Hennings, M Pfeifer and W G Bessler
      Molecular Pharmacology May 1983, 23 (3) 698-702;

  5. Birdsall, N J

    1. Modification of the binding properties of muscarinic receptors by gallamine.
      J M Stockton, N J Birdsall, A S Burgen and E C Hulme
      Molecular Pharmacology May 1983, 23 (3) 551-557;

  6. Black, K A

    1. Effects of nitrous oxide and methotrexate administration on hepatic methionine synthetase and dihydrofolate reductase activities, hepatic folates, and formate oxidation in rats.
      K A Black and T R Tephly
      Molecular Pharmacology May 1983, 23 (3) 724-730;

  7. Bockaert, J

    1. Pharmacological characterization of the D2 dopamine receptor negatively coupled with adenylate cyclase in rat anterior pituitary.
      A Enjalbert and J Bockaert
      Molecular Pharmacology May 1983, 23 (3) 576-584;

  8. Burgen, A S

    1. Modification of the binding properties of muscarinic receptors by gallamine.
      J M Stockton, N J Birdsall, A S Burgen and E C Hulme
      Molecular Pharmacology May 1983, 23 (3) 551-557;

C

  1. Chang, H

    1. Identification of 2-imidazolines as anti-sickling agents.
      H Chang, S M Ewert and R L Nagel
      Molecular Pharmacology May 1983, 23 (3) 731-734;

  2. Chemnitius, J M

    1. Inhibition of brain carboxylesterases by neurotoxic and nonneurotoxic organophosphorus compounds.
      J M Chemnitius and R Zech
      Molecular Pharmacology May 1983, 23 (3) 717-723;

  3. Combest, W L

    1. Alteration in cyclic AMP-dependent protein kinases and polyamine biosynthetic enzymes during hypertrophy and hyperplasia of the thyroid in the rat.
      W L Combest and D H Russell
      Molecular Pharmacology May 1983, 23 (3) 641-647;

  4. Craviso, G L

    1. High-affinity dextromethorphan binding sites in guinea pig brain. I. Initial characterization.
      G L Craviso and J M Musacchio
      Molecular Pharmacology May 1983, 23 (3) 619-628;
    2. High-affinity dextromethorphan binding sites in guinea pig brain. II. Competition experiments.
      G L Craviso and J M Musacchio
      Molecular Pharmacology May 1983, 23 (3) 629-640;

  5. Creese, I

    1. Interactions of ergot alkaloids with anterior pituitary D-2 dopamine receptors.
      D R Sibley and I Creese
      Molecular Pharmacology May 1983, 23 (3) 585-593;

D

  1. Douglas, K T

    1. Ionization processes of some harmala alkaloids.
      K T Douglas, R K Sharma, J F Walmsley and R C Hider
      Molecular Pharmacology May 1983, 23 (3) 614-618;

  2. Dumbrille-Ross, A

    1. Binding of [3H]Ro 11-2465. Possible identification of a subclass of [3H]imipramine binding sites.
      A Dumbrille-Ross and S W Tang
      Molecular Pharmacology May 1983, 23 (3) 607-613;

  3. Dwyer, L A

    1. Source of the oxygen atom in the product of cytochrome P-450-catalyzed N-demethylation reactions.
      G L Kedderis, L A Dwyer, D E Rickert and P F Hollenberg
      Molecular Pharmacology May 1983, 23 (3) 758-760;

E

  1. Edwards, M C

    1. Tumor-promoting and nonpromoting proinflammatory esters act as human lymphocyte mitogens with different sensitivities to inhibition by cyclosporin A.
      M C Edwards, A M Nouri, D Gordon and F J Evans
      Molecular Pharmacology May 1983, 23 (3) 703-708;

  2. Eling, T E

    1. An electron spin resonance study of the activation of benzidine by peroxidases.
      P D Josephy, T E Eling and R P Mason
      Molecular Pharmacology May 1983, 23 (3) 766-770;

  3. Enjalbert, A

    1. Pharmacological characterization of the D2 dopamine receptor negatively coupled with adenylate cyclase in rat anterior pituitary.
      A Enjalbert and J Bockaert
      Molecular Pharmacology May 1983, 23 (3) 576-584;

  4. Enna, S J

    1. [3H]tetrahydrotrazodone binding. Association with serotonin binding sites.
      D A Kendall, D P Taylor and S J Enna
      Molecular Pharmacology May 1983, 23 (3) 594-599;

  5. Evans, F J

    1. Tumor-promoting and nonpromoting proinflammatory esters act as human lymphocyte mitogens with different sensitivities to inhibition by cyclosporin A.
      M C Edwards, A M Nouri, D Gordon and F J Evans
      Molecular Pharmacology May 1983, 23 (3) 703-708;

  6. Ewert, S M

    1. Identification of 2-imidazolines as anti-sickling agents.
      H Chang, S M Ewert and R L Nagel
      Molecular Pharmacology May 1983, 23 (3) 731-734;

F

  1. Fischer, P H

    1. Modulation of the metabolism and cytotoxicity of iododeoxyuridine by 5'-amino-5'-deoxythymidine.
      P H Fischer, M A Weddle and R D Mossie
      Molecular Pharmacology May 1983, 23 (3) 709-716;

  2. Frye, R A

    1. Phospholipase A2 inhibitors block catecholamine secretion and calcium uptake in cultured bovine adrenal medullary cells.
      R A Frye and R W Holz
      Molecular Pharmacology May 1983, 23 (3) 547-550;

G

  1. Gordon, D

    1. Tumor-promoting and nonpromoting proinflammatory esters act as human lymphocyte mitogens with different sensitivities to inhibition by cyclosporin A.
      M C Edwards, A M Nouri, D Gordon and F J Evans
      Molecular Pharmacology May 1983, 23 (3) 703-708;

  2. Grove, J R

    1. Analysis of glucocorticoid-inducible genes in wild-type and variant rat hepatoma cells.
      J L Vannice, J R Grove and G M Ringold
      Molecular Pharmacology May 1983, 23 (3) 779-785;

H

  1. Hennings, G

    1. Interaction of metal-complexing compounds with lymphocytes and lymphoid cell lines.
      G Jung, G Hennings, M Pfeifer and W G Bessler
      Molecular Pharmacology May 1983, 23 (3) 698-702;

  2. Hider, R C

    1. Ionization processes of some harmala alkaloids.
      K T Douglas, R K Sharma, J F Walmsley and R C Hider
      Molecular Pharmacology May 1983, 23 (3) 614-618;

  3. Hollenberg, P F

    1. Source of the oxygen atom in the product of cytochrome P-450-catalyzed N-demethylation reactions.
      G L Kedderis, L A Dwyer, D E Rickert and P F Hollenberg
      Molecular Pharmacology May 1983, 23 (3) 758-760;

  4. Holz, R W

    1. Phospholipase A2 inhibitors block catecholamine secretion and calcium uptake in cultured bovine adrenal medullary cells.
      R A Frye and R W Holz
      Molecular Pharmacology May 1983, 23 (3) 547-550;

  5. Hulme, E C

    1. Modification of the binding properties of muscarinic receptors by gallamine.
      J M Stockton, N J Birdsall, A S Burgen and E C Hulme
      Molecular Pharmacology May 1983, 23 (3) 551-557;

  6. Hyman, A L

    1. Inhibition of human platelet aggregation by S-nitrosothiols. Heme-dependent activation of soluble guanylate cyclase and stimulation of cyclic GMP accumulation.
      B T Mellion, L J Ignarro, C B Myers, E H Ohlstein, B A Ballot, A L Hyman and P J Kadowitz
      Molecular Pharmacology May 1983, 23 (3) 653-664;

I

  1. Ignarro, L J

    1. Inhibition of human platelet aggregation by S-nitrosothiols. Heme-dependent activation of soluble guanylate cyclase and stimulation of cyclic GMP accumulation.
      B T Mellion, L J Ignarro, C B Myers, E H Ohlstein, B A Ballot, A L Hyman and P J Kadowitz
      Molecular Pharmacology May 1983, 23 (3) 653-664;

  2. Ionescu, M

    1. Effect of chlorpromazine on proteins in human erythrocyte membranes as inferred from spin labeling and biochemical analyses.
      G Benga, M Ionescu, O Popescu and V I Pop
      Molecular Pharmacology May 1983, 23 (3) 771-778;

J

  1. Jakoby, W B

    1. Cysteine conjugate beta-lyase.
      J Stevens and W B Jakoby
      Molecular Pharmacology May 1983, 23 (3) 761-765;

  2. Javitch, J A

    1. 3h-substance P binding to salivary gland membranes. Regulation by guanyl nucleotides and divalent cations.
      C M Lee, J A Javitch and S H Snyder
      Molecular Pharmacology May 1983, 23 (3) 563-569;

  3. Jaworski, C J

    1. Glucocorticoids increase GTP-dependent adenylate cyclase activity in cultured fibroblasts.
      G S Johnson and C J Jaworski
      Molecular Pharmacology May 1983, 23 (3) 648-652;

  4. Jefcoate, C R

    1. Modulation of microsomal benzo[a]pyrene metabolism by DNA.
      G M Keller and C R Jefcoate
      Molecular Pharmacology May 1983, 23 (3) 735-742;

  5. Jeffery, E H

    1. Interaction of constitutive and phenobarbital-induced cytochrome P-450 isozymes during the sequential oxidation of benzphetamine. Explanation for the difference in benzphetamine-induced hydrogen peroxide production and 455-nm complex formation in microsomes from untreated and phenobarbital-treated rats.
      E H Jeffery and G J Mannering
      Molecular Pharmacology May 1983, 23 (3) 748-757;

  6. Johnson, G S

    1. Glucocorticoids increase GTP-dependent adenylate cyclase activity in cultured fibroblasts.
      G S Johnson and C J Jaworski
      Molecular Pharmacology May 1983, 23 (3) 648-652;

  7. Josephy, P D

    1. An electron spin resonance study of the activation of benzidine by peroxidases.
      P D Josephy, T E Eling and R P Mason
      Molecular Pharmacology May 1983, 23 (3) 766-770;

  8. Jung, G

    1. Interaction of metal-complexing compounds with lymphocytes and lymphoid cell lines.
      G Jung, G Hennings, M Pfeifer and W G Bessler
      Molecular Pharmacology May 1983, 23 (3) 698-702;

K

  1. Kadowitz, P J

    1. Inhibition of human platelet aggregation by S-nitrosothiols. Heme-dependent activation of soluble guanylate cyclase and stimulation of cyclic GMP accumulation.
      B T Mellion, L J Ignarro, C B Myers, E H Ohlstein, B A Ballot, A L Hyman and P J Kadowitz
      Molecular Pharmacology May 1983, 23 (3) 653-664;

  2. Kedderis, G L

    1. Source of the oxygen atom in the product of cytochrome P-450-catalyzed N-demethylation reactions.
      G L Kedderis, L A Dwyer, D E Rickert and P F Hollenberg
      Molecular Pharmacology May 1983, 23 (3) 758-760;

  3. Keller, G M

    1. Modulation of microsomal benzo[a]pyrene metabolism by DNA.
      G M Keller and C R Jefcoate
      Molecular Pharmacology May 1983, 23 (3) 735-742;

  4. Kendall, D A

    1. [3H]tetrahydrotrazodone binding. Association with serotonin binding sites.
      D A Kendall, D P Taylor and S J Enna
      Molecular Pharmacology May 1983, 23 (3) 594-599;

L

  1. Lajtha, A

    1. A portion of [3H]cocaine binding in brain is associated with serotonergic neurons.
      M E Reith, H Sershen, D L Allen and A Lajtha
      Molecular Pharmacology May 1983, 23 (3) 600-606;

  2. Lambeth, J D

    1. 22-Ketocholesterol. A potent competitive inhibitor of cytochrome P-450scc-dependent side-chain cleavage of cholesterol.
      J D Lambeth
      Molecular Pharmacology May 1983, 23 (3) 743-747;

  3. Lee, C M

    1. 3h-substance P binding to salivary gland membranes. Regulation by guanyl nucleotides and divalent cations.
      C M Lee, J A Javitch and S H Snyder
      Molecular Pharmacology May 1983, 23 (3) 563-569;

  4. Lin, C W

    1. The determination of dissociation constants for substance P and substance P analogues in the guinea pig ileum by pharmacological procedures.
      C W Lin and J M Musacchio
      Molecular Pharmacology May 1983, 23 (3) 558-562;

M

  1. Mannering, G J

    1. Interaction of constitutive and phenobarbital-induced cytochrome P-450 isozymes during the sequential oxidation of benzphetamine. Explanation for the difference in benzphetamine-induced hydrogen peroxide production and 455-nm complex formation in microsomes from untreated and phenobarbital-treated rats.
      E H Jeffery and G J Mannering
      Molecular Pharmacology May 1983, 23 (3) 748-757;

  2. Mason, R P

    1. An electron spin resonance study of the activation of benzidine by peroxidases.
      P D Josephy, T E Eling and R P Mason
      Molecular Pharmacology May 1983, 23 (3) 766-770;

  3. Mellion, B T

    1. Inhibition of human platelet aggregation by S-nitrosothiols. Heme-dependent activation of soluble guanylate cyclase and stimulation of cyclic GMP accumulation.
      B T Mellion, L J Ignarro, C B Myers, E H Ohlstein, B A Ballot, A L Hyman and P J Kadowitz
      Molecular Pharmacology May 1983, 23 (3) 653-664;

  4. Mossie, R D

    1. Modulation of the metabolism and cytotoxicity of iododeoxyuridine by 5'-amino-5'-deoxythymidine.
      P H Fischer, M A Weddle and R D Mossie
      Molecular Pharmacology May 1983, 23 (3) 709-716;

  5. Musacchio, J M

    1. The determination of dissociation constants for substance P and substance P analogues in the guinea pig ileum by pharmacological procedures.
      C W Lin and J M Musacchio
      Molecular Pharmacology May 1983, 23 (3) 558-562;
    2. High-affinity dextromethorphan binding sites in guinea pig brain. I. Initial characterization.
      G L Craviso and J M Musacchio
      Molecular Pharmacology May 1983, 23 (3) 619-628;
    3. High-affinity dextromethorphan binding sites in guinea pig brain. II. Competition experiments.
      G L Craviso and J M Musacchio
      Molecular Pharmacology May 1983, 23 (3) 629-640;

  6. Myers, C B

    1. Inhibition of human platelet aggregation by S-nitrosothiols. Heme-dependent activation of soluble guanylate cyclase and stimulation of cyclic GMP accumulation.
      B T Mellion, L J Ignarro, C B Myers, E H Ohlstein, B A Ballot, A L Hyman and P J Kadowitz
      Molecular Pharmacology May 1983, 23 (3) 653-664;

N

  1. Nadel, J A

    1. Postsynaptic alpha 2-adrenoceptors predominate over alpha 1-adrenoceptors in canine tracheal smooth muscle and mediate neuronal and hormonal alpha-adrenergic contraction.
      P J Barnes, B E Skoogh, J A Nadel and J M Roberts
      Molecular Pharmacology May 1983, 23 (3) 570-575;

  2. Nagel, R L

    1. Identification of 2-imidazolines as anti-sickling agents.
      H Chang, S M Ewert and R L Nagel
      Molecular Pharmacology May 1983, 23 (3) 731-734;

  3. Nouri, A M

    1. Tumor-promoting and nonpromoting proinflammatory esters act as human lymphocyte mitogens with different sensitivities to inhibition by cyclosporin A.
      M C Edwards, A M Nouri, D Gordon and F J Evans
      Molecular Pharmacology May 1983, 23 (3) 703-708;

O

  1. Ohlstein, E H

    1. Inhibition of human platelet aggregation by S-nitrosothiols. Heme-dependent activation of soluble guanylate cyclase and stimulation of cyclic GMP accumulation.
      B T Mellion, L J Ignarro, C B Myers, E H Ohlstein, B A Ballot, A L Hyman and P J Kadowitz
      Molecular Pharmacology May 1983, 23 (3) 653-664;

P

  1. Pfeifer, M

    1. Interaction of metal-complexing compounds with lymphocytes and lymphoid cell lines.
      G Jung, G Hennings, M Pfeifer and W G Bessler
      Molecular Pharmacology May 1983, 23 (3) 698-702;

  2. Pocock, G

    1. Ionic and metabolic requirements for stimulation of secretion by ouabain in bovine adrenal medullary cells.
      G Pocock
      Molecular Pharmacology May 1983, 23 (3) 671-680;
    2. Ion movements in isolated bovine adrenal medullary cells treated with ouabain.
      G Pocock
      Molecular Pharmacology May 1983, 23 (3) 681-697;

  3. Pop, V I

    1. Effect of chlorpromazine on proteins in human erythrocyte membranes as inferred from spin labeling and biochemical analyses.
      G Benga, M Ionescu, O Popescu and V I Pop
      Molecular Pharmacology May 1983, 23 (3) 771-778;

  4. Popescu, O

    1. Effect of chlorpromazine on proteins in human erythrocyte membranes as inferred from spin labeling and biochemical analyses.
      G Benga, M Ionescu, O Popescu and V I Pop
      Molecular Pharmacology May 1983, 23 (3) 771-778;

R

  1. Reith, M E

    1. A portion of [3H]cocaine binding in brain is associated with serotonergic neurons.
      M E Reith, H Sershen, D L Allen and A Lajtha
      Molecular Pharmacology May 1983, 23 (3) 600-606;

  2. Rickert, D E

    1. Source of the oxygen atom in the product of cytochrome P-450-catalyzed N-demethylation reactions.
      G L Kedderis, L A Dwyer, D E Rickert and P F Hollenberg
      Molecular Pharmacology May 1983, 23 (3) 758-760;

  3. Ringold, G M

    1. Analysis of glucocorticoid-inducible genes in wild-type and variant rat hepatoma cells.
      J L Vannice, J R Grove and G M Ringold
      Molecular Pharmacology May 1983, 23 (3) 779-785;

  4. Roberts, J M

    1. Postsynaptic alpha 2-adrenoceptors predominate over alpha 1-adrenoceptors in canine tracheal smooth muscle and mediate neuronal and hormonal alpha-adrenergic contraction.
      P J Barnes, B E Skoogh, J A Nadel and J M Roberts
      Molecular Pharmacology May 1983, 23 (3) 570-575;

  5. Russell, D H

    1. Alteration in cyclic AMP-dependent protein kinases and polyamine biosynthetic enzymes during hypertrophy and hyperplasia of the thyroid in the rat.
      W L Combest and D H Russell
      Molecular Pharmacology May 1983, 23 (3) 641-647;

S

  1. Sershen, H

    1. A portion of [3H]cocaine binding in brain is associated with serotonergic neurons.
      M E Reith, H Sershen, D L Allen and A Lajtha
      Molecular Pharmacology May 1983, 23 (3) 600-606;

  2. Sharma, R K

    1. Ionization processes of some harmala alkaloids.
      K T Douglas, R K Sharma, J F Walmsley and R C Hider
      Molecular Pharmacology May 1983, 23 (3) 614-618;

  3. Sibley, D R

    1. Interactions of ergot alkaloids with anterior pituitary D-2 dopamine receptors.
      D R Sibley and I Creese
      Molecular Pharmacology May 1983, 23 (3) 585-593;

  4. Silver, P J

    1. Effects of the calmodulin antagonist, fluphenazine, on phosphorylation of myosin and phosphorylase in intact smooth muscle.
      P J Silver and J T Stull
      Molecular Pharmacology May 1983, 23 (3) 665-670;

  5. Skoogh, B E

    1. Postsynaptic alpha 2-adrenoceptors predominate over alpha 1-adrenoceptors in canine tracheal smooth muscle and mediate neuronal and hormonal alpha-adrenergic contraction.
      P J Barnes, B E Skoogh, J A Nadel and J M Roberts
      Molecular Pharmacology May 1983, 23 (3) 570-575;

  6. Snyder, S H

    1. 3h-substance P binding to salivary gland membranes. Regulation by guanyl nucleotides and divalent cations.
      C M Lee, J A Javitch and S H Snyder
      Molecular Pharmacology May 1983, 23 (3) 563-569;

  7. Stevens, J

    1. Cysteine conjugate beta-lyase.
      J Stevens and W B Jakoby
      Molecular Pharmacology May 1983, 23 (3) 761-765;

  8. Stockton, J M

    1. Modification of the binding properties of muscarinic receptors by gallamine.
      J M Stockton, N J Birdsall, A S Burgen and E C Hulme
      Molecular Pharmacology May 1983, 23 (3) 551-557;

  9. Stull, J T

    1. Effects of the calmodulin antagonist, fluphenazine, on phosphorylation of myosin and phosphorylase in intact smooth muscle.
      P J Silver and J T Stull
      Molecular Pharmacology May 1983, 23 (3) 665-670;

T

  1. Tang, S W

    1. Binding of [3H]Ro 11-2465. Possible identification of a subclass of [3H]imipramine binding sites.
      A Dumbrille-Ross and S W Tang
      Molecular Pharmacology May 1983, 23 (3) 607-613;

  2. Taylor, D P

    1. [3H]tetrahydrotrazodone binding. Association with serotonin binding sites.
      D A Kendall, D P Taylor and S J Enna
      Molecular Pharmacology May 1983, 23 (3) 594-599;

  3. Tephly, T R

    1. Effects of nitrous oxide and methotrexate administration on hepatic methionine synthetase and dihydrofolate reductase activities, hepatic folates, and formate oxidation in rats.
      K A Black and T R Tephly
      Molecular Pharmacology May 1983, 23 (3) 724-730;

V

  1. Vannice, J L

    1. Analysis of glucocorticoid-inducible genes in wild-type and variant rat hepatoma cells.
      J L Vannice, J R Grove and G M Ringold
      Molecular Pharmacology May 1983, 23 (3) 779-785;

W

  1. Walmsley, J F

    1. Ionization processes of some harmala alkaloids.
      K T Douglas, R K Sharma, J F Walmsley and R C Hider
      Molecular Pharmacology May 1983, 23 (3) 614-618;

  2. Weddle, M A

    1. Modulation of the metabolism and cytotoxicity of iododeoxyuridine by 5'-amino-5'-deoxythymidine.
      P H Fischer, M A Weddle and R D Mossie
      Molecular Pharmacology May 1983, 23 (3) 709-716;

Z

  1. Zech, R

    1. Inhibition of brain carboxylesterases by neurotoxic and nonneurotoxic organophosphorus compounds.
      J M Chemnitius and R Zech
      Molecular Pharmacology May 1983, 23 (3) 717-723;
Back to top

In this issue

Advertisement